Diagnosis and management of interstitial lung disease
暂无分享,去创建一个
[1] E. Savarino,et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. , 2009, American journal of respiratory and critical care medicine.
[2] G. Raghu,et al. Silent gastro-oesophageal reflux and microaspiration in IPF: mounting evidence for anti-reflux therapy? , 2012, European Respiratory Journal.
[3] I. Noth,et al. Interstitial lung disease and gastroesophageal reflux disease: key role of esophageal function tests in the diagnosis and treatment. , 2011, Arquivos de gastroenterologia.
[4] K. Brown,et al. Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease , 2011, European Respiratory Journal.
[5] David A Lynch,et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. , 2005, American journal of respiratory and critical care medicine.
[6] A. Wells,et al. Acute Exacerbations of Idiopathic Pulmonary Fibrosis , 2013, Respiration.
[7] K. Anstrom,et al. Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. , 2013, Chest.
[8] S. Sahn,et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. , 2011, American journal of respiratory and critical care medicine.
[9] Joyce S Lee,et al. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. , 2013, The Lancet. Respiratory medicine.
[10] M. Glassberg,et al. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing. , 2013, American journal of respiratory and critical care medicine.
[11] Sang-Do Lee,et al. Mortality and risk factors for surgical lung biopsy in patients with idiopathic interstitial pneumonia. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[12] K. Anstrom,et al. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. , 2012, American journal of respiratory and critical care medicine.
[13] Susan Murray,et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? , 2004, American journal of respiratory and critical care medicine.
[14] S. Sahn,et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials , 2011, The Lancet.
[15] A. Wells,et al. The evolving pharmacotherapy of pulmonary fibrosis , 2013, Expert opinion on pharmacotherapy.
[16] C. Strange,et al. Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines. , 2012, Chest.
[17] G. Hunninghake,et al. Idiopathic pulmonary fibrosis. , 2001, The New England journal of medicine.
[18] T. Maher,et al. Current and novel drug therapies for idiopathic pulmonary fibrosis , 2012, Drug design, development and therapy.
[19] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[20] S. Kimmel,et al. Association between pulmonary fibrosis and coronary artery disease. , 2004, Archives of internal medicine.
[21] K. Meyer,et al. Interstitial lung disease in the elderly: pathogenesis, diagnosis and management. , 2011, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[22] Johny Verschakelen,et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. , 2005, The New England journal of medicine.
[23] H. Collard,et al. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis , 2011, European Respiratory Journal.
[24] A. Rahmel,et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report--2011. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[25] H. Collard,et al. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. , 2010, The New England journal of medicine.
[26] Luca Richeldi,et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. , 2011, The New England journal of medicine.
[27] S. Rosselot. Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[28] Charlie Strange,et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. , 2012, American journal of respiratory and critical care medicine.
[29] S. Nathan,et al. Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases , 2013, Current opinion in pulmonary medicine.
[30] G. Raghu,et al. GER and Aspiration in Interstitial Lung Disease , 2012 .
[31] N. Kaminski,et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. , 2012, American journal of respiratory and critical care medicine.
[32] H. Collard,et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[33] K. Meyer,et al. Review: Therapies for interstitial lung disease: past, present and future , 2008, Therapeutic advances in respiratory disease.
[34] F. Martinez,et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. , 2006, American journal of respiratory and critical care medicine.
[35] T. Pincus,et al. Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease. , 2010, Respiratory medicine.
[36] N. Todd,et al. Molecular and cellular mechanisms of pulmonary fibrosis , 2012, Fibrogenesis & tissue repair.
[37] Joyce S Lee,et al. Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis , 2012, Thorax.
[38] C. Ruppert,et al. Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis , 2012, European Respiratory Review.
[39] G. Raghu,et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. , 1991, The American review of respiratory disease.
[40] S. Nathan,et al. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. , 2010, Respiratory medicine.
[41] G. Raghu,et al. Pirfenidone in idiopathic pulmonary fibrosis , 2009, European Respiratory Journal.
[42] F. Martinez,et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. , 2003, American journal of respiratory and critical care medicine.
[43] Arnold Simanowitz,et al. international consensus statement , 2000 .
[44] David A. Lynch,et al. Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .
[45] R. Cornwell,et al. Lung transplant for interstitial lung disease: outcomes for single versus bilateral lung transplantation. , 2012, Interactive cardiovascular and thoracic surgery.
[46] H. Collard,et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. , 2009, Chest.
[47] K. Chida,et al. Cumulative incidence of and predictive factors for lung cancer in IPF , 2009, Respirology.
[48] American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). , 2000, American journal of respiratory and critical care medicine.
[49] G. Raghu,et al. Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis. , 2005, Chest.
[50] T. Johkoh,et al. Acute exacerbation of interstitial pneumonia following surgical lung biopsy. , 2006, Respiratory medicine.
[51] H. Collard,et al. Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials , 2013, Respiratory Research.
[52] H. Collard,et al. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. , 2012, American journal of respiratory and critical care medicine.
[53] H. Collard,et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.
[54] E. Savarino,et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients , 2013, European Respiratory Journal.
[55] C. Pellegrini,et al. Typical GERD symptoms and esophageal pH monitoring are not enough to diagnose pharyngeal reflux. , 2005, The Journal of surgical research.
[56] Keith McNeil,et al. International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT). , 1998, American journal of respiratory and critical care medicine.
[57] G. Raghu,et al. Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? , 2011, European Respiratory Journal.
[58] Moisés Selman,et al. Idiopathic pulmonary fibrosis , 2011, The Lancet.
[59] D. Fairclough,et al. Pirfenidone in idiopathic pulmonary fibrosis , 2010 .
[60] K. Meyer,et al. Immunosuppressive therapy for autoimmune lung diseases. , 2012, Immunology and allergy clinics of North America.
[61] S. Sahn,et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. , 2011, American journal of respiratory and critical care medicine.
[62] K. Meyer,et al. Optimizing post-transplant outcomes in lung transplantation , 2008, Expert review of respiratory medicine.
[63] M. Tamm,et al. Diagnostic yield of flexible bronchoscopy in current clinical practice. , 2006, Swiss medical weekly.
[64] Shandra L. Protzko,et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. , 2013, American journal of respiratory and critical care medicine.
[65] H. Date,et al. [Lung transplantation]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.
[66] D. S. Kim. Acute exacerbations in patients with idiopathic pulmonary fibrosis , 2013, Respiratory Research.
[67] Kevin J Anstrom,et al. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. , 2012, The New England journal of medicine.
[68] K. Meyer,et al. Surgical lung biopsy for the diagnosis of interstitial lung disease: a review of the literature and recommendations for optimizing safety and efficacy. , 2013, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[69] K. Anstrom,et al. The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis. , 2012, Respiratory medicine.
[70] T. Colby,et al. Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis. , 2013, Chest.
[71] David P. Naidich,et al. Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature. , 2013, American journal of respiratory and critical care medicine.
[72] A. Nicholson,et al. Fibrotic idiopathic interstitial pneumonias: HRCT findings that predict mortality , 2011, European Radiology.
[73] O. Hilberg,et al. Idiopathic Pulmonary Fibrosis - Diagnosis and Treatment , 2014 .
[74] D. Schroeder,et al. High short-term mortality following lung biopsy for usual interstitial pneumonia. , 2001, The European respiratory journal.
[75] R. D. du Bois,et al. Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease , 2013, The Journal of Rheumatology.
[76] J. Kanne. Interstitial lung disease (ILD): imaging finding, and the role of imaging in evaluating the patient with known or suspected ILD. , 2010, Seminars in roentgenology.
[77] F. Martinez,et al. International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[78] A. Nicholson,et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. , 2003, American journal of respiratory and critical care medicine.
[79] S. Palmer,et al. Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. , 2011, Chest.
[80] F. Martinez,et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema , 2010, European Respiratory Journal.
[81] L. Rose,et al. Patient evaluation. , 1987, Dental clinics of North America.
[82] A. Oikonomou,et al. A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis , 2013, Journal of Translational Medicine.